Novocure breach exposes data of over 1,400 patients
🔒 Novocure, a global oncology company, reported a mid‑August incident in which unauthorized actors accessed certain information systems, exposing data for more than 1,400 U.S. cancer patients and an undisclosed number of employees. The company says most patient records contained ID numbers without names, while fewer than 50 patients in the western U.S. had identifying and provider contact details exposed. Novocure confirmed no medical devices were accessed and its operations remain functional, and it is evaluating regulatory notification obligations.
